- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05140967
Effects of Training Intensity on Physical Fitness and Body Composition in Cystic Fibrosis
February 13, 2025 updated by: Prof. Dr. Dr. Anja Bosy-Westphal, University of Kiel
Effects of Endurance Training Intensity on Exercise Capacity, Body Composition, and Appetite Regulation in Cystic Fibrosis
Aim of the randomized controlled trial is to investigate the effects of endurance training with different intensities on physical performance, body composition and appetite regulation in people with cystic fibrosis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Schleswig-Holstein
-
Nebel / Amrum, Schleswig-Holstein, Germany, 25946
- Fachklink Satteldüne der DRV Nord
-
St. Peter-Ording, Schleswig-Holstein, Germany, 25826
- Strandklinik St. Peter-Ording
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- confirmed diagnosis of cystic fibrosis by at least 2 sweat tests and / or by the presence of two CF mutations,
- willingness to participate in and to comply with the research project procedure,
- written informed consent of patients,
- age ≥ 18 years,
- FEV1 of pred. ≥ 40%,
- Stable condition (as indicated by absence of one or more signs: new or increased haemoptysis, increased malaise, fatigue or lethargy, temperature over 38°C, weight loss, sinus pain and a decrease in pulmonary function by 10% or more)
Exclusion Criteria:
- Severe pulmonary exacerbation,
- cor pulmonale,
- musculoskeletal discomfort that makes a regular exercise training impossible,
- untreated CF-related diabetes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High Intensity Interval Training (A)
Exercise training with intermittent bouts of high intensity
|
High Intensity Interval Training
|
|
Experimental: Moderate Intensity Continous Training (B)
Exercise training with constant workload
|
Moderate Intensity Continuous Training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in Peak Oxygen Uptake
Time Frame: at baseline and after 4 weeks of exercise training program
|
measured with peak Oxygen uptake (VO2) in percent predicted
|
at baseline and after 4 weeks of exercise training program
|
|
change in Peak Workload
Time Frame: at baseline and after 4 weeks of exercise training program
|
measured with peak Workload in percent predicted
|
at baseline and after 4 weeks of exercise training program
|
|
change body fat mass index
Time Frame: at baseline and after 4 weeks of exercise training program
|
measured with body fat mass index (FMI) in kg / m*2
|
at baseline and after 4 weeks of exercise training program
|
|
change in Body fat free mass index
Time Frame: at baseline and after 4 weeks of exercise training program
|
measured with fat free body mass index (FFMI) in kg / m*2
|
at baseline and after 4 weeks of exercise training program
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in Forced Expiratory Volume in 1 second
Time Frame: at baseline and after 4 weeks of exercise training program
|
measured with Forced Expiratory Volume in 1 second (FEV1) in percent predicted
|
at baseline and after 4 weeks of exercise training program
|
|
change in Health related quality of life
Time Frame: at baseline and six and twelve months after completion of exercise training program
|
measured with the Cystic Fibrosis Questionnaire Revised (CFQ-R); 9 Quality of life domains: Physical, role/school, vitality, emotion, social, body image, eating, treatment burden, health perceptions: 3 symptom scales: Weight, respiratory, and digestion Scores range from 0 to 100, with higher scores indicating better health.
|
at baseline and six and twelve months after completion of exercise training program
|
|
appetite control - subjective feeling of hunger
Time Frame: at baseline and after 4 weeks of exercise training program
|
measured with visual analogue scales.
The scale consists of a 10 cm vertical line anchored with "not hungry at all" at the left side and with "extremely hungry" at the right side.
|
at baseline and after 4 weeks of exercise training program
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Chair: Anja Bosy-Westhphal, Prof, PhD, MD, Insitute of Human Nutrition, University of Kiel
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 15, 2021
Primary Completion (Actual)
December 31, 2023
Study Completion (Actual)
December 31, 2024
Study Registration Dates
First Submitted
October 29, 2021
First Submitted That Met QC Criteria
December 1, 2021
First Posted (Actual)
December 2, 2021
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 13, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Keywords
- Exercise training
- Exercise capacity
- Health related quality of life
- Body-composition
- Appetite regulating hormones
- ad libitum energy intake
- Habitual physical activity
- High Intensity Interval Training (HIIT)
- Moderate Intensity Continuous Training (MICT)
- Peak Oxygen uptake (VO2peak)
- Subjective appetite and satiety ratings
Additional Relevant MeSH Terms
Other Study ID Numbers
- ABW-2021-CF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cystic Fibrosis
-
Hospital de Clinicas de Porto AlegreUnknownCystic Fibrosis | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in Children | Cystic Fibrosis With ExacerbationBrazil
-
Dartmouth-Hitchcock Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingCystic Fibrosis (CF) | Cystic Fibrosis Gastrointestinal DiseaseUnited States
-
Haisco Pharmaceutical Group Co., Ltd.RecruitingNon-cystic Fibrosis BronchiectasisChina
-
AstraZenecaRecruitingNon-cystic Fibrosis BronchiectasisChina
-
Alexander HorsleyRecruitingCystic Fibrosis (CF) | Cystic Fibrosis Pulmonary ExacerbationUnited Kingdom
-
Reistone Biopharma Company LimitedRecruiting
-
University of Colorado, DenverCystic Fibrosis FoundationTerminatedCystic Fibrosis-related Diabetes | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in ChildrenUnited States
-
Royal College of Surgeons, IrelandThe Hospital for Sick Children; Imperial College London; Erasmus Medical Center; University College Dublin and other collaboratorsActive, not recruitingCystic Fibrosis | Adherence, Medication | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis in Children | Cystic Fibrosis Liver DiseaseUnited Kingdom, Ireland
-
Herlev and Gentofte HospitalCopenhagen University Hospital, DenmarkActive, not recruitingMyocardial Infarction | Heart Diseases | Heart Failure | Stroke | Cystic Fibrosis | Heart Failure, Diastolic | Heart Failure, Systolic | Left Ventricular Dysfunction | Cystic Fibrosis-related Diabetes | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis of Pancreas | Cystic Fibrosis, Pulmonary | Cystic...Denmark
-
Alexander HorsleyRecruitingCystic Fibrosis (CF) | Cystic Fibrosis Pulmonary ExacerbationUnited Kingdom
Clinical Trials on High Intensity Interval Training (HIIT)
-
Wroclaw University of Health and Sport SciencesActive, not recruitingPhysical Activity | Blood Pressure | Cardiorespiratory Fitness | Adipose Tissue | AdolescentsPoland
-
Université de SherbrookeRecruiting
-
Mayo ClinicActive, not recruitingCardiac RehabilitationUnited States
-
Karolinska University HospitalKarolinska InstitutetUnknownDermatomyositis | PolymyositisSweden
-
Wu JiarunCompletedBurnout,Motivation,Stress,Mental ToughnessMalaysia
-
McMaster UniversityCompleted
-
Chang Gung Memorial HospitalCompletedHeart Failure | Morality | Remodeling, VentricularTaiwan
-
Brock UniversityCompletedCardiovascular Diseases | Metabolic SyndromeCanada
-
University of North Carolina, Chapel HillEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedKnee OsteoarthritisUnited States
-
Amsterdam UMC, location VUmcRecruitingExercise | Brain Tumor, PrimaryNetherlands